Management of In-Transit Disease

This is a clinical practice guideline for patients with melanoma who have developed in-transit metastases. The guideline discusses the treatment of in-transit disease, and provides recommendations on primary treatment, second-line treatment, adjuvant treatment, and radiation therapy. The primary outcomes of interest are progression-free survival and overall survival.